Objectives: Endometrial adenocarcinoma after risk-reducing salpingo-oophorectomy (RRSO) is rare. There have been reports of an increased incidence of high-risk uterine cancer in BRCA positive women, both among those taking tamoxifen and those who were not. However, low risk uterine cancer in BRCA positive women after RRSO has not been observed.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Gynecologic Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2014 Published by Elsevier Inc.